Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Multisensory Approaches for Managing Pediatric Dental Anxiety

23 septembre 2026 mis à jour par: Mustafa Sarp Kaya, Bezmialem Vakif University

Evaluation of the Effects of Virtual Reality and Weighted Blanket Use on Dental Anxiety Among School-Aged Children With High Dental Anxiety

The purpose of this prospective, randomized, single-blind clinical study is to evaluate and compare the effectiveness of distraction using virtual reality (VR) glasses and deep-pressure stimulation using weighted blankets on dental anxiety, cooperation, and pain perception in school-aged children. The study focuses on children aged 5-9 years with high dental anxiety (CFSS-DS score ≥39) who require dental procedures involving local anesthesia, such as Class II restorations, pulpotomy, or extractions. Participants will be randomly assigned to four groups: a control group receiving standard behavior guidance, a VR group, a weighted blanket group, and a combined group using both VR and weighted blankets. The study aims to determine the effects of these non-pharmacological, non-invasive, sensory-based interventions on children's clinical experience and physiological parameters.

Aperçu de l'étude

Description détaillée

This clinical trial is designed as a four-arm, randomized controlled study to compare sensory-based behavior guidance techniques in pediatric dentistry.

Study Arms:

Group 1 (Control): Treatment with basic behavior guidance techniques.

Group 2 (VR): Treatment using virtual reality (VR) glasses as a distraction tool.

Group 3 (WB): Treatment using a 3-kg weighted blanket for deep-pressure stimulation.

Group 4 (Combined): Simultaneous use of VR glasses and a weighted blanket.

Methodology:

Children aged 5-9 years who meet the inclusion criteria will be evaluated at multiple time points: pre-treatment, during local anesthesia, and post-treatment.

Outcome Measures:

Dental Anxiety: Assessed using the Facial Image Scale (FIS) and the Children's Fear Survey Schedule-Dental Subscale (CFSS-DS).

Cooperation: Evaluated using the Frankl Behavior Rating Scale and the FLACC (Face, Legs, Activity, Cry, Consolability) scale.

Pain Perception: Measured using the Wong-Baker FACES Pain Rating Scale.

Physiological Parameters: Heart rate and oxygen saturation will be monitored throughout the procedure.

Acceptability: Subjective feedback from children and parents will be collected via post-treatment surveys to assess the feasibility of and satisfaction with the interventions.

Inclusion is restricted to systemically healthy children (ASA I-II) whose body weight (15-30 kg) is compatible with the 3-kg weighted blanket to ensure safety and appropriate therapeutic pressure.

Type d'étude

Interventionnel

Inscription (Estimé)

60

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Sauvegarde des contacts de l'étude

  • Nom: Mustafa Sarp Kaya, Associate Professor
  • Numéro de téléphone: +90 532 230 68 01
  • E-mail: mskaya@bezmialem.edu.tr

Lieux d'étude

    • Fatih
      • Istanbul, Fatih, Turquie (Türkiye), 34093
        • Recrutement
        • Bezm-i Alem Vakif University, Faculty of Dentistry, Department of Pediatric Dentistry

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

5 ans à 9 ans (Enfant)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Children aged between 5 and 9 years.
  • Children with a total score of 39 or higher on the Children's Fear Survey Schedule-Dental Subscale (CFSS-DS).
  • Requirement for dental treatment necessitating local anesthesia, such as Class II restorations, pulpotomy, pulpectomy, or extractions.
  • Systemically healthy children classified as ASA I or ASA II.
  • Voluntary participation of both the child and the parent, with written informed consent obtained from the parent.
  • Body weight between 15 and 30 kg, ensuring that the 3-kg weighted blanket corresponds to 10-20% of the child's body weight.

Exclusion Criteria:

  • Children with a CFSS-DS score of 38 or lower.
  • Presence of intellectual or developmental disabilities.
  • Presence of visual or hearing impairments.
  • Presence of neurodevelopmental or neurological disorders, such as epilepsy.
  • Acute or chronic respiratory diseases.
  • Neuromuscular or orthopedic conditions that may pose a risk during the use of the weighted blanket.
  • History of dizziness, nausea, or vertigo associated with virtual reality use.
  • Refusal of the specific interventions, namely VR glasses or the weighted blanket, by the child or the parent.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: Control Group

Participants in this group will receive dental treatment using only basic behavior guidance techniques, such as tell-show-do and positive reinforcement, without any additional sensory interventions.

Traditional non-pharmacological behavior management techniques, including the "Tell-Show-Do" method, positive reinforcement, and distraction through verbal communication, will be used as a standard protocol.

Expérimental: Virtual Reality Group

Participants will wear virtual reality (VR) glasses during the dental procedure. The VR system will be used as a visual and auditory distraction tool to reduce dental anxiety and pain perception.

The participant will wear a Virtual Reality headset during the dental procedure. Audio-visual content specifically selected for pediatric distraction will be played to divert the child's attention away from dental stimuli and reduce anxiety.

Expérimental: Weighted Blanket Group

Participants will be covered with a 3-kg weighted blanket during the dental procedure to provide deep-pressure stimulation. This non-pharmacological intervention aims to promote relaxation and reduce physiological stress responses.

A 3 kg weighted blanket will be placed over the participant's body during the dental treatment. This intervention aims to provide deep pressure stimulation to promote relaxation and decrease behavioral stress responses.

Expérimental: Combined Intervention Group

Participants in this group will receive a combination of the two interventions during the entire dental procedure: virtual reality (VR) glasses for distraction and a weighted blanket for deep-pressure stimulation.

The participant will wear a Virtual Reality headset during the dental procedure. Audio-visual content specifically selected for pediatric distraction will be played to divert the child's attention away from dental stimuli and reduce anxiety.

A 3 kg weighted blanket will be placed over the participant's body during the dental treatment. This intervention aims to provide deep pressure stimulation to promote relaxation and decrease behavioral stress responses.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Children's Fear Survey Schedule-Dental Subscale (CFSS-DS) Score
Délai: During the dental examination session, before dental treatment.

Dental fear and anxiety will be assessed using the Children's Fear Survey Schedule-Dental Subscale (CFSS-DS). The total score ranges from 15 to 75, with higher scores indicating greater dental fear and anxiety.

During the dental examination session, before dental treatment.
Facial Image Scale (FIS) Score
Délai: Immediately before dental treatment, immediately after local anesthetic injection, and immediately after completion of dental treatment.

Dental anxiety will be assessed using the Facial Image Scale (FIS), a 5-point facial image scale ranging from 1 to 5, with higher scores indicating greater dental anxiety. FIS scores will be recorded at three time points: immediately before dental treatment, immediately after local anesthetic injection, and immediately after completion of dental treatment.

Immediately before dental treatment, immediately after local anesthetic injection, and immediately after completion of dental treatment.
Frankl Behavior Rating Scale Score
Délai: Immediately before dental treatment ande immediately after dental treatment.

Child behavior and cooperation during dental treatment will be assessed using the Frankl Behavior Rating Scale, which categorizes behavior into four levels ranging from definitely negative to definitely positive.

Immediately before dental treatment ande immediately after dental treatment.
FLACC Behavioral Pain Assessment Score
Délai: Immediately before dental treatment, immediately after local anesthetic injection, and immediately after completion of dental treatment.

Pain-related behavioral responses will be assessed using the FLACC (Face, Legs, Activity, Cry, Consolability) scale. The total score ranges from 0 to 10, with higher scores indicating greater pain-related behavioral response. Assessment will be performed by an independent evaluator blinded to group allocation using standardized video recordings.

Immediately before dental treatment, immediately after local anesthetic injection, and immediately after completion of dental treatment.
Wong-Baker FACES Pain Rating Scale Score
Délai: Immediately before and immediately after local anesthetic injection.

Self-reported pain intensity will be assessed using the Wong-Baker FACES Pain Rating Scale, ranging from 0 to 10, with higher scores indicating greater pain intensity.

Immediately before and immediately after local anesthetic injection.
Heart Rate
Délai: Immediately before dental treatment, immediately before and immediately after local anesthetic injection and immediately after completion of dental treatment.

Heart rate will be measured in beats per minute (bpm) using a pulse oximeter.

Immediately before dental treatment, immediately before and immediately after local anesthetic injection and immediately after completion of dental treatment.
Peripheral Oxygen Saturation (SpO₂)
Délai: Immediately before dental treatment, immediately before and immediately after local anesthetic injection and immediately after completion of dental treatment.

Peripheral oxygen saturation (SpO₂) will be measured using a pulse oximeter and recorded as percentage (%).

Immediately before dental treatment, immediately before and immediately after local anesthetic injection and immediately after completion of dental treatment.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Mustafa Sarp Kaya, Associate Professor, Bezm-i Alem Vakif University, Faculty of Dentistry, Department of Pediatric Dentistry

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

19 août 2026

Achèvement primaire (Estimé)

1 avril 2027

Achèvement de l'étude (Estimé)

1 avril 2027

Dates d'inscription aux études

Première soumission

23 mai 2026

Première soumission répondant aux critères de contrôle qualité

23 septembre 2026

Première publication (Réel)

30 septembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

30 septembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

23 septembre 2026

Dernière vérification

1 septembre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Individual participant data will not be shared to protect participant confidentiality and privacy in accordance with the ethical committee approval and local data protection regulations.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner